Pharmagenesis, INC.
About us | We have a TCM-derived SFDA-approved injectable product on the market as an adjunctive therapy in cancer chemotherapy. In additional, a natural product-derived semisynthetic agent that we developed for primary cancer therapy is about to enter European Phase II clinical trials through an out-licensing agreement with a major French company. We have a significant joint venture efforts in the Far East. |
---|---|
Industry Focus | Pharmaceutical Chemicals, Herb Medicine, Plant Extract |
Products/Services | Natural products, plants and plant extracts from herbal and Chinese traditional medicine, triptolide-related compounds triptolide-related |
Our Markets | Worldwide |
No. of Employees | 11 - 50 People |
Annual Sales Range(USD) | Below US$1 Million |
Year Established | 1991 |
Legal Representative(CEO) | John H. Musser, Ph.D., COO |
Certificates | . |